Viridien
Short position disclosed on October 21, 2026.
10.49% of the capital sold short
9 disclosing funds
2,528 disclosures on record
Evolution of the disclosed total
0%5%10%15%
Jan 2026Apr 2026Jul 2026Oct 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Marshall Wace LLP | 1.99% | unchanged | October 20, 2026 | ||
| Capital Fund Management | 1.69% | new | October 19, 2026 | ||
| Citadel Advisors LLC | 1.46% | new | October 21, 2026 | ||
| Worldquant, LLC | 1.29% | new | October 15, 2026 | ||
| Acadian Asset Management LLC | 1.10% | new | October 19, 2026 | ||
| Tudor Capital Europe LLP | 0.80% | new | October 1, 2026 | ||
| Walleye Capital LLC | 0.80% | new | October 5, 2026 | ||
| TWO Sigma Investments, LP | 0.79% | new | October 19, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 15,164 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| January 17, 2024 | Millennium Capital Management France | 0.57% | January 24, 2024 | |
| January 16, 2024 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 | |
| January 15, 2024 | Marshall Wace LLP | 2.28% | March 24, 2025 | |
| January 15, 2024 | Qube Research & Technologies Limited | 1.47% | March 4, 2024 | |
| January 15, 2024 | Citadel Advisors LLC | 1.00% | March 20, 2024 | |
| January 12, 2024 | Marshall Wace LLP | 2.31% | March 24, 2025 | |
| January 12, 2024 | Qube Research & Technologies Limited | 1.53% | March 4, 2024 | |
| January 12, 2024 | Citadel Advisors LLC | 0.87% | March 20, 2024 | |
| January 12, 2024 | Millennium International Management LP | 0.59% | January 24, 2024 | |
| January 12, 2024 | Millennium Capital Management France | 0.35% | January 16, 2024 | |
| January 11, 2024 | Marshall Wace LLP | 2.27% | March 24, 2025 | |
| January 11, 2024 | Citadel Advisors LLC | 0.73% | March 20, 2024 | |
| January 11, 2024 | Millennium Capital Management France | 0.50% | January 16, 2024 | |
| January 10, 2024 | Qube Research & Technologies Limited | 1.47% | March 4, 2024 | |
| January 10, 2024 | Millennium International Management LP | 0.70% | January 24, 2024 | |
| January 10, 2024 | Millennium Capital Management France | 0.62% | January 16, 2024 | |
| January 10, 2024 | Citadel Advisors LLC | 0.60% | March 20, 2024 | |
| January 9, 2024 | Qube Research & Technologies Limited | 1.16% | March 4, 2024 | |
| January 9, 2024 | Millennium International Management LP | 0.69% | January 24, 2024 | |
| January 9, 2024 | Millennium Capital Management France | 0.58% | January 16, 2024 | |
| January 8, 2024 | Qube Research & Technologies Limited | 0.95% | March 4, 2024 | |
| January 4, 2024 | Marshall Wace LLP | 2.13% | March 24, 2025 | |
| January 4, 2024 | Qube Research & Technologies Limited | 0.86% | March 4, 2024 | |
| January 3, 2024 | Qube Research & Technologies Limited | 0.93% | March 4, 2024 | |
| January 2, 2024 | Qube Research & Technologies Limited | 0.88% | March 4, 2024 | |
| December 29, 2023 | Qube Research & Technologies Limited | 0.99% | March 4, 2024 | |
| December 28, 2023 | Qube Research & Technologies Limited | 1.00% | March 4, 2024 | |
| December 27, 2023 | Marshall Wace LLP | 2.29% | March 24, 2025 | |
| December 27, 2023 | Qube Research & Technologies Limited | 0.95% | March 4, 2024 | |
| December 22, 2023 | Marshall Wace LLP | 2.39% | March 24, 2025 | |
| December 22, 2023 | Qube Research & Technologies Limited | 1.01% | March 4, 2024 | |
| December 21, 2023 | Qube Research & Technologies Limited | 1.20% | March 4, 2024 | |
| December 20, 2023 | Marshall Wace LLP | 2.49% | March 24, 2025 | |
| December 19, 2023 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 | |
| December 18, 2023 | Marshall Wace LLP | 2.50% | March 24, 2025 | |
| December 18, 2023 | Qube Research & Technologies Limited | 1.43% | March 4, 2024 | |
| December 15, 2023 | Qube Research & Technologies Limited | 1.38% | March 4, 2024 | |
| December 14, 2023 | Marshall Wace LLP | 2.45% | March 24, 2025 | |
| December 14, 2023 | Qube Research & Technologies Limited | 1.47% | March 4, 2024 | |
| December 13, 2023 | Marshall Wace LLP | 2.37% | March 24, 2025 | |
| December 11, 2023 | Qube Research & Technologies Limited | 1.14% | March 4, 2024 | |
| December 8, 2023 | Marshall Wace LLP | 2.21% | March 24, 2025 | |
| December 8, 2023 | Qube Research & Technologies Limited | 1.08% | March 4, 2024 | |
| December 7, 2023 | Marshall Wace LLP | 2.14% | March 24, 2025 | |
| December 7, 2023 | Millennium Capital Management France | 0.49% | December 11, 2023 | |
| December 6, 2023 | Qube Research & Technologies Limited | 0.75% | March 4, 2024 | |
| December 6, 2023 | Millennium Capital Management France | 0.61% | December 11, 2023 | |
| December 5, 2023 | Qube Research & Technologies Limited | 0.96% | March 4, 2024 | |
| December 5, 2023 | Millennium Capital Management France | 0.53% | December 11, 2023 | |
| December 4, 2023 | Qube Research & Technologies Limited | 1.10% | March 4, 2024 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 2,528 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.60% of the capital sold short
- Valeo 11.47% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- FDJ United 6.58% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.53% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.73% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
- Gecina 3.32% of the capital sold short
- Forvia 3.25% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at October 21, 2026, https://www.quivad.com/action/viridien?page=11